Unknown affiliation
Verified email at
Cited by
Cited by
B lymphocytes secrete antigen-presenting vesicles.
G Raposo, HW Nijman, W Stoorvogel, R Liejendekker, CV Harding, ...
Journal of Experimental Medicine 183 (3), 1161-1172, 1996
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
MJM Gooden, GH de Bock, N Leffers, T Daemen, HW Nijman
British journal of cancer 105 (1), 93-103, 2011
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, ...
International Journal of Gynecologic Cancer 26 (1), 2016
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
N Leffers, MJM Gooden, RA de Jong, BN Hoogeboom, A Klaske, ...
Cancer Immunology, Immunotherapy 58 (3), 449, 2009
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
JGA Houbiers, HW Nijman, SH Van Der Burg, JW Drijfhout, P Kenemans, ...
European journal of immunology 23 (9), 2072-2077, 1993
Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial
RA Nout, H Putter, IM Jürgenliemk-Schulz, JJ Jobsen, LCHW Lutgens, ...
Journal of Clinical Oncology 27 (21), 3547-3556, 2009
Identification of peptide sequences that potentially trigger HLA‐A2. 1‐restricted cytotoxic T lymphocytes
HW Nijman, JGA Houbiers, MPM Vierboom, SH van der Burg, ...
European journal of immunology 23 (6), 1215-1219, 1993
Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes
MPM Vierboom, HW Nijman, R Offringa, EIH Voort, T Hall, L Broek, ...
The Journal of experimental medicine 186 (5), 695-704, 1997
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.
HW Nijman, MJ Kleijmeer, MA Ossevoort, VM Oorschot, MP Vierboom, ...
The Journal of experimental medicine 182 (1), 163-174, 1995
Lymphvascular space involvement: an independent prognostic factor in endometrial cancer
JM Briët, H Hollema, N Reesink, JG Aalders, MJE Mourits, A Klaske, ...
Gynecologic oncology 96 (3), 799-804, 2005
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
E Stelloo, T Bosse, RA Nout, HJ MacKay, DN Church, HW Nijman, ...
Modern pathology 28 (6), 836-844, 2015
Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer—combined analysis of the PORTEC cohorts
E Stelloo, RA Nout, EM Osse, IJ Jürgenliemk-Schulz, JJ Jobsen, ...
Clinical cancer research 22 (16), 4215-4224, 2016
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre …
SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ...
The lancet oncology 19 (3), 295-309, 2018
Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer
FM Speetjens, PJK Kuppen, MJP Welters, F Essahsah, MGK Lantrua, ...
Clinical Cancer Research 15 (3), 1086-1095, 2009
POLE proofreading mutations elicit an antitumor immune response in endometrial cancer
IC van Gool, FA Eggink, L Freeman-Mills, E Stelloo, E Marchi, M de Bruyn, ...
Clinical Cancer Research 21 (14), 3347-3355, 2015
Myeloid derived suppressor cells—an overview of combat strategies to increase immunotherapy efficacy
O Draghiciu, J Lubbers, HW Nijman, T Daemen
Oncoimmunology 4 (1), e954829, 2015
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide
M Röpke, J Hald, P Guldberg, J Zeuthen, L Nørgaard, L Fugger, ...
Proceedings of the National Academy of Sciences 93 (25), 14704-14707, 1996
Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid?
CA Koelman, ABC Coumans, HW Nijman, IIN Doxiadis, GA Dekker, ...
Journal of reproductive immunology 46 (2), 155-166, 2000
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
M Gooden, M Lampen, ES Jordanova, N Leffers, JB Trimbos, ...
Proceedings of the National Academy of Sciences 108 (26), 10656-10661, 2011
Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial
N Leffers, AJA Lambeck, MJM Gooden, BN Hoogeboom, R Wolf, ...
International Journal of Cancer 125 (9), 2104-2113, 2009
The system can't perform the operation now. Try again later.
Articles 1–20